EV/EBITDA
-0.05
+0.08+61.54%
14 min ago
Summary
- As of February 25, 2025, VTGN EV/EBITDA is -0.05, with a rise of +0.08 (+61.54%) during the most recent trading day.
- Over the past year, VTGN EV/EBITDA has increased by +0.32 (+86.49%).
- VTGN EV/EBITDA is now -105.32% below its all-time high of 0.94.
Performance
VTGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VTGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +61.5% | -62.3% | -5.4% |
| 1 m1 month | +76.2% | -76.4% | -11.8% |
| 3 m3 months | -141.7% | +146.7% | -5.1% |
| 6 m6 months | 0.0% | +39.1% | -31.1% |
| ytdytd | +77.3% | -77.6% | -12.4% |
| 1 y1 year | +86.5% | -79.0% | -48.2% |
| 5 y5 years | +96.5% | -92.2% | -86.1% |
VTGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.27 | +81.5% | |
| 3 m | 3-month | 0.43 | -111.6% | -0.43 | +88.4% |
| 6 m | 6-month | 0.53 | -109.4% | -0.43 | +88.4% |
| 1 y | 1-year | 0.94 | -105.3% | -1.01 | +95.0% |
| 3 y | 3-year | 0.94 | -105.3% | -6.21 | +99.2% |
| 5 y | 5-year | 0.94 | -105.3% | -26.80 | +99.8% |
| alltime | all time | 0.94 | -105.3% | -2765 | +100.0% |
VistaGen Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.05(-77.3%) |
| 2024 | -0.22(-42.1%) |
| 2023 | -0.38(-2000.0%) |
| 2022 | 0.02(-100.2%) |
| 2021 | -8.81(-23.7%) |
| 2020 | -11.55(+691.1%) |
| 2019 | -1.46(-12.6%) |
| Date | Value |
|---|---|
| 2018 | -1.67(+65.3%) |
| 2017 | -1.01(+87.0%) |
| 2016 | -0.54(+31.7%) |
| 2015 | -0.41(-88.2%) |
| 2014 | -3.46(-24.3%) |
| 2013 | -4.57(+208.8%) |
| 2012 | -1.48(-79.2%) |
| 2011 | -7.10 |
FAQ
- What is VistaGen Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for VistaGen Therapeutics?
- What is VTGN EV/EBITDA year-to-date change?
- What is VistaGen Therapeutics EV/EBITDA year-on-year change?
What is VistaGen Therapeutics EV/EBITDA?
The current EV/EBITDA of VTGN is -0.05
What is the all time high EV/EBITDA for VistaGen Therapeutics?
VistaGen Therapeutics all-time high EV/EBITDA is 0.94
What is VTGN EV/EBITDA year-to-date change?
VistaGen Therapeutics EV/EBITDA has changed by +0.17 (+77.27%) since the beginning of the year
What is VistaGen Therapeutics EV/EBITDA year-on-year change?
Over the past year, VTGN EV/EBITDA has changed by +0.32 (+86.49%)